Similar articles

• Haematological effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in man.

  Peters MJ, Breslin AB, Kemp AS, Chu J, Berend N. Peters MJ, et al. Thorax. 1992 Apr;47(4):284-7. doi: 10.1136/thx.47.4.284. Thorax. 1992. PMID: 1585293 Free PMC article.
• Alteration of the N-formyl-methionyl-leucyl-phenylalanine-induced response in cystic fibrosis neutrophils.

  Kemp T, Schram-Doumont A, van Geffel R, Kram R, Szpirer C. Kemp T, et al. Pediatr Res. 1986 Jun;20(6):520-6. doi: 10.1203/00006450-198606000-00008. Pediatr Res. 1986. PMID: 3086828
• Effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in the well elderly and in patients with chronic bronchitis.

  Peters MJ, Breslin AB, Berend N. Peters MJ, et al. Thorax. 1992 Apr;47(4):279-83. doi: 10.1136/thx.47.4.279. Thorax. 1992. PMID: 1585292 Free PMC article.
• Inadequate superoxide production by canine neutrophils in response to the combination of N-formyl-methionyl-leucyl-phenylalanine and cytochalasin B.

  Ing TS, Yu AW, Patel M, Gupta V, Khan MA, Agrawal A, Patel P. Ing TS, et al. Am J Vet Res. 1994 Feb;55(2):288-90. Am J Vet Res. 1994. PMID: 8172421
• The main functions and structural modifications of tripeptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a chemotactic factor.

  Yang KH, Fang H, Ye JS, Gong JZ, Wang JT, Xu WF. Yang KH, et al. Pharmazie. 2008 Nov;63(11):779-83. Pharmazie. 2008. PMID: 19069235 Review.